AMSBIO is a leading company contributing to drug discovery by providing cutting-edge life science products and services. AMSBIO offers magnetic bead technology, antibodies, peptides, recombinant proteins, and has a significant tissue biorepository. The company is able to draw upon in-depth expertise to provide solutions for studying cell motility, migration, invasion, proliferation, organoid and spheroid culture, regenerative medicine, stem cell research, and mitochondrial toxicity. New high-throughput microfluidics screening technology will be launched at SLAS 2018.
1035 Cambridge St
Cambridge, MA 02141